The Tower, Trinity TEC
About Inflazome Ltd.Utilizing the scientific expertise of our founders and advisors, Inflazome is leading the way in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome, which is now thought to drive many chronic inflammatory conditions.
Founder: Matt Cooper and Luke O’Neill
Currently, there are no jobs for this employer on BioSpace.
Browse jobs with BioSpace Featured Employers here.